BIO vs RVTY · rev $651.0M vs P/E 42, rev $1.44B
BIO (BIO) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
BIO currently screens at market cap $0. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the BIO and RVTY stock pages for the full models.
Not investment advice.